Clorox Company

Clorox's RSI of 26.1 signals deeply oversold conditions, suggesting the market has punished this $12.7B sanitization leader excessively. Trading at a 13.9 P/E ratio—reasonable for a defensive consumer staple—the stock appears undervalued relative to its stable cash-generation profile. Short interest sits at 7.81% of float, substantial enough to create squeeze potential if sentiment shifts. The absence of any 52-week high proximity reinforces that CLX has retreated meaningfully from recent peaks, likely due to margin pressures or macro headwinds. This combination of beaten-down technicals and a valuation that doesn't yet reflect panic-induced desperation suggests the risk-reward tilts toward mean reversion territory.